Spyre Therapeutics, Inc. (SYRE) at a glance

Spyre Therapeutics, Inc. (SYRE) is a Healthcare company. It trades at $83.46. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Momentum (86/100) and its weakest is Income (40/100).

Price
$83.46
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$13.93 to $84.63
Vestovix Score54/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
86